R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
KITE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KITE
ST13
US500000097784457Class
36, 40, 44, 45
Filing
97784457
Registration
7351256
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
02/07/2025
Trademark type
Word
Nice classes
36, 40, 44, 45
Filing date
02/07/2023
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
02/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2020
First use in commerce
01/01/2020
Drawing code
4
Owner type
03
Owner location
Santa Monica, CA
Examiner
FLINT, DANIEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kite Pharma, Inc.
Representatives
Cynthia Smuzynska GILEAD SCIENCES, INC.
Technical classification
Nice Classes
Class 36Class 40Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services
Class 40
Custom manufacturing of biological tissuebloodcells; custom manufacturing of pharmaceutical preparations for immunotherapy
Class 44
Providing medical information in the fields of oncologyimmunology and cell therapy; providing a web site featuring medical information in the fields of oncologyimmunology and cell therapy; providing medical informationconsultancy and advisory services in the fields of oncologyimmunology and cell therapy; all of the foregoing excluding any services related to optometryophthalmology or other ocular care; collection and preservation of biological tissueblood and cells
Class 45
Providing patient advocate services in the field of the treatment of diseases and disorders in the fields of cancer treatmentsimmunotherapy and cell therapy treatments
Publications
History of USPTO decisions and trademark events.
18 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/13/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2023
GNRT
NON-FINAL ACTION E-MAILED
06/15/2023
CNRT
NON-FINAL ACTION WRITTEN
06/15/2023
DOCK
ASSIGNED TO EXAMINER
06/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2023
NWAP
NEW APPLICATION ENTERED
02/10/2023
Continuous trademark protection
Get notified about every new filing that threatens KITE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.